News Image

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Provided By GlobeNewswire

Last update: Oct 10, 2025

Nutriband initiates commercial worldwide brand name development for its lead product, an abuse deterrent transdermal system.

Nutriband has partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.

Read more at globenewswire.com

NUTRIBAND INC -CW26

NASDAQ:NTRBW (10/17/2025, 8:00:01 PM)

2.5

+0.29 (+13.12%)


NUTRIBAND INC

NASDAQ:NTRB (10/17/2025, 8:00:01 PM)

After market: 7.2622 -0.22 (-2.91%)

7.48

-0.22 (-2.86%)



Find more stocks in the Stock Screener

Follow ChartMill for more